MENU
IMDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Insight Molecular Diagnostics (IMDX) Ownership - Who owns Insight Molecular Diagnostics?

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes... Show more

Profile

Industry
Medical Specialties
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
166.83M
P/E Ratio
N/A
Total Cash
18.69M
Projected Growth
N/A
Total Debt
3.13M
Revenue
4.4M
Risk (Beta)
2.06
Dividend Yield
N/A
Total Cash/Share
0.65
Total Debt/Equity
N/A
Revenue/Share
0.16 USD as % of share price

Fundamentals

IMDX
Capitalization
167M
P/E Ratio
N/A
Risk (Beta)
2.06
Dividend Yield
N/A
Total Cash
18.7M
Total Cash/Share
0.65
Total Debt
3.13M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.16%
Revenue
4.4M
ROE
N/A
Book Value
-9.2M
P/B Ratio
196.08
Cash Flow
N/A
Earnings
-3.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
369M
Current Ratio
2.79
Current Revenue Per Employee
5306.12
Dividends Per Share - Security
N/A
EBITDA
-58.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
53.46
Revenue To Assets
-106.49
Shares Held By Institutions
55.9M
Shares Outstanding - Current
28.7M
Total Liabilities
53.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
144.538
View a ticker or compare two or three
IMDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a developer of ovel, non-invasive, liquid biopsy diagnostics for the early detection of cancer

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A